用mycophenolate成功长期治疗管间炎和脑膜炎
Liam Qi1,2, Shaun Chandler3, Prianka Puri3,2
1Department of Nephrology, Queensland Health, Brisbane, Queensland, Australia liamyqi@gmail.com.
BMJ case reports
|November 6, 2025
概括
管介质炎和脑膜炎 (TINU) 综合征可以导致急性损伤. 甲酸莫菲蒂尔有效地管理了一名TINU患者,提供了成功的类固醇节约治疗选择.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 眼科医生 眼科 眼科
- 类风湿病学 类风湿病学
背景情况:
- 管间炎和脑膜炎 (TINU) 综合征表现为脑膜炎和急性损伤.
- 皮质类固醇是主要的治疗方法,但对类固醇节约剂的数据有限.
研究的目的:
- 报告一个成功长期治疗TINU综合征的案例,使用mycophenolate mofetil作为一种类固醇节约剂.
主要方法:
- 一个病例报告,一名60多岁的女性患者因TINU而出现急性功能衰竭.
- 开始全身性皮质类固醇,其次是mycophenolate mofetil,由于类固醇诱导的副作用.
- 在2.5年内监测功能和临床状态.
主要成果:
- 患者在开始服用mycophenolate mofetil后,功能显著改善.
- 成功管理TINU综合征,持续健康2.5年.
- 没有证据表明有活跃的类固醇症,尽管有 vulval sarcoidosis 的病史.
结论:
- 甲酸莫菲提尔在治疗TINU综合征方面表现出成功的长期结果,作为一种类固醇节约剂.
- 这一案例突出了为患有皮质类固醇显著副作用的患者提供可行的替代方案.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
447
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
447
Kidney Transplant II: Surgical Procedure
270
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
270
Pulmonary Tuberculosis V
516
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
516
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
402
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
402
Myocarditis IV: Nursing Management
190
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
190
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
435
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
435


